Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1502)	1/12/2006 12:24:06 PM
From: Jibacoa	Read Replies (2) of 3722

PCYC Continues to try closing its Dec.19 downgap.<g> The stock is up today 7% on volume of 765Ks bigcharts.marketwatch.com Dec.19 was when it announced that Xcytrin didn't show statistically significant changes in lung cancer patients with cerebral metastases that were treated for a year combined with radiotherapy, compared with those that were treated with radiation therapy alone. (Although patients taking Xcytrin took 5.4 months longer to progress compared with those receiving radiation alone, that was not considered enough significant difference.) PCYC reportedly has around $3.25 in csh/shr, the insiders hold more than 10% of th stock and it seems that it has a good chance of closing the Dec. downgap.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next